|
1
|
Di Ciaula A and Portincasa P: Recent
advances in understanding and managing cholesterol gallstones.
F1000Res. 7(F1000 Faculty Rev-1529)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hsing AW, Gao YT, Han TQ, Rashid A, Sakoda
LC, Wang BS, Shen MC, Zhang BH, Niwa S, Chen J and Fraumeni JF Jr:
Gallstones and the risk of biliary tract cancer: A population-based
study in China. Br J Cancer. 97:1577–1582. 2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sutherland JM, Mok J, Liu G, Karimuddin A
and Crump T: A cost-utility study of laparoscopic cholecystectomy
for the treatment of symptomatic gallstones. J Gastrointest Surg.
24:1314–1319. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rebholz C, Krawczyk M and Lammert F:
Genetics of gallstone disease. Eur J Clin Invest.
48(e12935)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Arrese M, Cortés V, Barrera F and Nervi F:
Nonalcoholic fatty liver disease, cholesterol gallstones, and
cholecystectomy: New insights on a complex relationship. Curr Opin
Gastroenterol. 34:90–96. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yuan S, Giovannucci EL and Larsson SC:
Gallstone disease, diabetes, calcium, triglycerides, smoking and
alcohol consumption and pancreatitis risk: Mendelian randomization
study. NPJ Genom Med. 6(27)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kono S, Eguchi H, Honjo S, Todoroki I, Oda
T, Shinchi K, Ogawa S and Nakagawa K: Cigarette smoking, alcohol
use, and gallstone risk in Japanese men. Digestion. 65:177–183.
2002.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kim HS, Cho SK, Kim CS and Park JS: Big
data and analysis of risk factors for gallbladder disease in the
young generation of Korea. PLoS One. 14(e0211480)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rhodes M and Venables C: Symptomatic
gallstones-a disease of non-smokers? Digestion. 49:221–226.
1991.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jørgensen T: Gall stones in a Danish
population. Relation to weight, physical activity, smoking, coffee
consumption, and diabetes mellitus. Gut. 30:528–534.
1989.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mohr GC, Kritz-Silverstein D and
Barrett-Connor E: Plasma lipids and gallbladder disease. Am J
Epidemiol. 134:78–85. 1991.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Claudel T, Zollner G, Wagner M and Trauner
M: Role of nuclear receptors for bile acid metabolism, bile
secretion, cholestasis, and gallstone disease. Biochim Biophys
Acta. 1812:867–878. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cedó L, Farràs M, Lee-Rueckert M and
Escolà-Gil JC: Molecular insights into the mechanisms underlying
the cholesterol-lowering effects of phytosterols. Curr Med Chem.
26:6704–6723. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Rudling M, Laskar A and Straniero S:
Gallbladder bile supersaturated with cholesterol in gallstone
patients preferentially develops from shortage of bile acids. J
Lipid Res. 60:498–505. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tsaroucha AK, Chatzaki E, Lambropoulou M,
Despoudi K, Laftsidis P, Charsou C, Polychronidis A, Papadopoulos N
and Simopoulos CE: Megalin and cubilin in the human gallbladder
epithelium. Clin Exp Med. 8:165–170. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Erranz B, Miquel JF, Argraves WS, Barth
JL, Pimentel F and Marzolo MP: Megalin and cubilin expression in
gallbladder epithelium and regulation by bile acids. J Lipid Res.
45:2185–2198. 2004.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Marzolo MP and Farfán P: New insights into
the roles of megalin/LRP2 and the regulation of its functional
expression. Biol Res. 44:89–105. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Housset C, Chrétien Y, Debray D and
Chignard N: Functions of the gallbladder. Compr Physiol.
6:1549–1577. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Willnow TE and Christ A: Endocytic
receptor LRP2/megalin-of holoprosencephaly and renal Fanconi
syndrome. Pflugers Arch. 469:907–916. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tsounapi P, Honda M, Dimitriadis F, Kimura
Y, Shimizu S, Kawamoto B, Hikita K, Saito M, Sofikitis N and
Takenaka A: MP07-15 alterations in oxidative stress parameters in
the testis and epididymis in a nicotine-exposed rat model. Can
nicotine-abstinence overcome the oxidative damage? J Urol.
197(e87)2017.
|
|
21
|
Moschetta A, Bookout AL and Mangelsdorf
DJ: Prevention of cholesterol gallstone disease by FXR agonists in
a mouse model. Nat Med. 10:1352–1358. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Young JW, Finlayson K, Spratt C, Marston
HM, Crawford N, Kelly JS and Sharkey J: Nicotine improves sustained
attention in mice: Evidence for involvement of the alpha7 nicotinic
acetylcholine receptor. Neuropsychopharmacology. 29:891–900.
2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Berrendero F, Mendizábal V, Robledo P,
Galeote L, Bilkei-Gorzo A, Zimmer A and Maldonado R:
Nicotine-induced antinociception, rewarding effects, and physical
dependence are decreased in mice lacking the preproenkephalin gene.
J Neurosci. 25:1103–1112. 2005.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Paulusma CC, Groen A, Kunne C, Ho-Mok KS,
Spijkerboer AL, Rudi de Waart D, Hoek FJ, Vreeling H, Hoeben KA,
van Marle J, et al: Atp8b1 deficiency in mice reduces resistance of
the canalicular membrane to hydrophobic bile salts and impairs bile
salt transport. Hepatology. 44:195–204. 2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Baron JA: Beneficial effects of nicotine
and cigarette smoking: The real, the possible and the spurious. Br
Med Bull. 52:58–73. 1996.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wolf R, Wolf D and Ruocco V: The benefits
of smoking in skin diseases 1. Clin Dermatol. 16:641–647.
1998.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wasilewski A, Zielińska M, Storr M and
Fichna J: Beneficial effects of probiotics, prebiotics, synbiotics,
and psychobiotics in inflammatory bowel disease. Inflamm Bowel Dis.
21:1674–1682. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mosher LR: Nicotinic acid side effects and
toxicity: A review. Am J Psychiatry. 126:1290–1296. 1970.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Rutledge SM and Asgharpour A: Smoking and
liver disease. Gastroenterol Hepatol (NY). 16:617–625.
2020.PubMed/NCBI
|
|
31
|
Li G, Chan YL, Wang B, Saad S, George J,
Oliver BG and Chen H: E-cigarettes damage the liver and alter
nutrient metabolism in pregnant mice and their offspring. Ann N Y
Acad Sci. 1475:64–77. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yue J, Miksys S, Hoffmann E and Tyndale
RF: Chronic nicotine treatment induces rat CYP2D in the brain but
not in the liver: An investigation of induction and time course:
2006 Innovations in neuropsychopharmacology award. J Psychiatry
Neurosci. 33:54–63. 2008.PubMed/NCBI
|
|
33
|
Chen XM, Li FQ, Yan S, Wu XC and Tang CL:
Nicotine alleviates the liver inflammation of non-alcoholic
steatohepatitis induced by high-fat and high-fructose in mice.
Beijing Da Xue Xue Bao Yi Xue Ban. 48:777–782. 2016.PubMed/NCBI(In Chinese).
|
|
34
|
Zhang D, Dai J, Cao Y, Wang Z and Qiao Z
and Qiao Z: Nicotine exposure of male mice protects offspring
against carbon tetrachloride-induced acute liver injury. J Biochem
Mol Toxicol. 36(e23069)2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhao J, Park S, Kim JW, Qi J, Zhou Z, Lim
CW and Kim B: Nicotine attenuates concanavalin A-induced liver
injury in mice by regulating the α7-nicotinic acetylcholine
receptor in Kupffer cells. Int Immunopharmacol.
78(106071)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Shabanzadeh DM and Novovic S: Alcohol,
smoking and benign hepato-biliary disease. Best Pract Res Clin
Gastroenterol. 31:519–527. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Aune D, Vatten LJ and Boffetta P: Tobacco
smoking and the risk of gallbladder disease. Eur J Epidemiol.
31:643–653. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kono S, Shinichi K, Ikeda N, Yanai F and
Imanishi K: Prevalence of gallstone disease in relation to smoking,
alcohol use, obesity, and glucose tolerance: A study of
self-defense officials in Japan. Am J Epidemiol. 136:787–794.
1992.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Degirmenci B, Albayrak R, Haktanir A, Acar
M and Yucel A: Acute effect of smoking on gallbladder emptying and
refilling in chronic smokers and nonsmokers: A sonographic study.
World J Gastroenterol. 12:5540–5543. 2006.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Trautwein EA, Kunath-Rau A and
Erbersdobler HF: Increased fecal bile acid excretion and changes in
the circulating bile acid pool are involved in the
hypocholesterolemic and gallstone-preventive actions of psyllium in
hamsters. J Nutr. 129:896–902. 1999.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Di Ciaula A, Garruti G, Lunardi Baccetto
R, Molina-Molina E, Bonfrate L, Wang DQ and Portincasa P: Bile acid
physiology. Ann Hepatol. 16 (Suppl 1):s4–s14. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Stofan M and Guo GL: Bile acids and FXR:
Novel targets for liver diseases. Front Med (Lausanne).
7(544)2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Dikkers A and Tietge UJF: The neglected
cousin of the hepatocyte: How gallbladder epithelial cells might
contribute to cholesterol gallstone formation. Dig Dis Sci.
58:296–298. 2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Miquel J, Moreno M, Amigo L, Molina H,
Mardones P, Wistuba II and Rigotti A: Expression and regulation of
scavenger receptor class B type I (SR-BI) in gall bladder
epithelium. Gut. 52:1017–1024. 2003.PubMed/NCBI View Article : Google Scholar
|
